source
- HHS issues temporary policy permitting compounding pharmacies to produce certain peptide drugsThe U.S. Department of Health and Human Services announced a new policy that temporarily authorizes compounding pharmacies to manufacture specific peptide products that are not otherwise commercial…
- HHS adopts enforcement discretion allowing compounding pharmacies to produce six unapproved peptidesHHS announced an "enforcement discretion" policy that permits compounding pharmacies to make six peptide products that have not received FDA approval. The list includes BPC-157 and TB-500, which a…